Patricia L. Morris

Array ( [id] => 4644478 [patent_doc_number] => 08022084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Polymorphic forms of a GABAA agonist' [patent_app_type] => utility [patent_app_number] => 11/813796 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3842 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022084.pdf [firstpage_image] =>[orig_patent_app_number] => 11813796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 278056 [patent_doc_number] => 07557131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Substituted triazole derivatives as oxytocin antagonists' [patent_app_type] => utility [patent_app_number] => 11/335940 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42025 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557131.pdf [firstpage_image] =>[orig_patent_app_number] => 11335940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667652 [patent_doc_number] => 20060173002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Heteroaryl compounds as P2Y1 receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/333050 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173002.pdf [firstpage_image] =>[orig_patent_app_number] => 11333050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5603022 [patent_doc_number] => 20060293367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide' [patent_app_type] => utility [patent_app_number] => 11/332275 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2242 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293367.pdf [firstpage_image] =>[orig_patent_app_number] => 11332275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242976 [patent_doc_number] => 20070021471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ethanolates' [patent_app_type] => utility [patent_app_number] => 11/332274 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4008 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021471.pdf [firstpage_image] =>[orig_patent_app_number] => 11332274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142566 [patent_doc_number] => 20070004782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'N-((2Z)-2-((4-Hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2' [patent_app_type] => utility [patent_app_number] => 11/332020 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7200 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004782.pdf [firstpage_image] =>[orig_patent_app_number] => 11332020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584460 [patent_doc_number] => 07449584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1' [patent_app_type] => utility [patent_app_number] => 11/331865 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7793 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449584.pdf [firstpage_image] =>[orig_patent_app_number] => 11331865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142565 [patent_doc_number] => 20070004781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Crystalline N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/332015 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3789 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004781.pdf [firstpage_image] =>[orig_patent_app_number] => 11332015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5603023 [patent_doc_number] => 20060293368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/332408 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2115 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293368.pdf [firstpage_image] =>[orig_patent_app_number] => 11332408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667839 [patent_doc_number] => 20060173189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Synthesis of himbacine analogs' [patent_app_type] => utility [patent_app_number] => 11/330935 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6325 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173189.pdf [firstpage_image] =>[orig_patent_app_number] => 11330935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 225091 [patent_doc_number] => 07605275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Exo- and diastereo- selective syntheses of himbacine analogs' [patent_app_type] => utility [patent_app_number] => 11/331324 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10664 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605275.pdf [firstpage_image] =>[orig_patent_app_number] => 11331324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814004 [patent_doc_number] => 20080194635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Crystalline Forms of Cis-5-Fluoro-N-[4-(2-Hydroxy-4-Methylbenzamido) Cyclohexyl]-2-(Tetrahydrothiopyran-4-Yloxy) Nicotinamide' [patent_app_type] => utility [patent_app_number] => 11/814382 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9537 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194635.pdf [firstpage_image] =>[orig_patent_app_number] => 11814382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844600 [patent_doc_number] => 20060122235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => '4-pyrrolidino-phenyl-benzyl ether derivatives' [patent_app_type] => utility [patent_app_number] => 11/325747 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18954 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122235.pdf [firstpage_image] =>[orig_patent_app_number] => 11325747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281857 [patent_doc_number] => 07553857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'S-omeprazole magnesium' [patent_app_type] => utility [patent_app_number] => 11/318236 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5420 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553857.pdf [firstpage_image] =>[orig_patent_app_number] => 11318236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949981 [patent_doc_number] => 20080306107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/721637 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14803 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306107.pdf [firstpage_image] =>[orig_patent_app_number] => 11721637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851864 [patent_doc_number] => 20060235055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Therapeutic agents useful for treating pain' [patent_app_type] => utility [patent_app_number] => 11/317832 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34887 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235055.pdf [firstpage_image] =>[orig_patent_app_number] => 11317832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662195 [patent_doc_number] => 20060252791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Imidazo[4,5-c]pyridine compound and method of antiviral treatment' [patent_app_type] => utility [patent_app_number] => 11/316050 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4235 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252791.pdf [firstpage_image] =>[orig_patent_app_number] => 11316050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649830 [patent_doc_number] => 20060135565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Crystalline form of rabeprazole sodium' [patent_app_type] => utility [patent_app_number] => 11/311141 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2256 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135565.pdf [firstpage_image] =>[orig_patent_app_number] => 11311141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693236 [patent_doc_number] => 20080086007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => '2-(Pyrazole-1-Yl)Pyridine Derivative' [patent_app_type] => utility [patent_app_number] => 11/793021 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20080086007.pdf [firstpage_image] =>[orig_patent_app_number] => 11793021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693237 [patent_doc_number] => 20080086008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Process for the Preparation of a 2-Pyridylethylcarboxamide Derivative' [patent_app_type] => utility [patent_app_number] => 11/793561 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9775 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20080086008.pdf [firstpage_image] =>[orig_patent_app_number] => 11793561 [rel_patent_id] =>[rel_patent_doc_number] =>)